These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 34108620)

  • 61. Hsa_circ_0128846 promotes tumorigenesis of colorectal cancer by sponging hsa-miR-1184 and releasing AJUBA and inactivating Hippo/YAP signalling.
    Wang X; Chen Y; Liu W; Liu T; Sun D
    J Cell Mol Med; 2020 Sep; 24(17):9908-9924. PubMed ID: 32681581
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Mst1 overexpression inhibited the growth of human non-small cell lung cancer in vitro and in vivo.
    Xu CM; Liu WW; Liu CJ; Wen C; Lu HF; Wan FS
    Cancer Gene Ther; 2013 Aug; 20(8):453-60. PubMed ID: 23928732
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Evodiamine inhibits proliferation and promotes apoptosis of hepatocellular carcinoma cells via the Hippo-Yes-Associated Protein signaling pathway.
    Zhao S; Xu K; Jiang R; Li DY; Guo XX; Zhou P; Tang JF; Li LS; Zeng D; Hu L; Ran JH; Li J; Chen DL
    Life Sci; 2020 Jun; 251():117424. PubMed ID: 32057900
    [TBL] [Abstract][Full Text] [Related]  

  • 64. miR-873-5p inhibits the progression of colon cancer via repression of tumor suppressor candidate 3/AKT signaling.
    Zhu Y; Zhang X; Qi M; Zhang Y; Ding F
    J Gastroenterol Hepatol; 2019 Dec; 34(12):2126-2134. PubMed ID: 31039290
    [TBL] [Abstract][Full Text] [Related]  

  • 65. YAP mediates the interaction between the Hippo and PI3K/Akt pathways in mesangial cell proliferation in diabetic nephropathy.
    Qian X; He L; Hao M; Li Y; Li X; Liu Y; Jiang H; Xu L; Li C; Wu W; Du L; Yin X; Lu Q
    Acta Diabetol; 2021 Jan; 58(1):47-62. PubMed ID: 32816106
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Platelet‑derived growth factor‑BB mediates pancreatic cancer malignancy via regulation of the Hippo/Yes‑associated protein signaling pathway.
    Li T; Guo T; Liu H; Jiang H; Wang Y
    Oncol Rep; 2021 Jan; 45(1):83-94. PubMed ID: 33416116
    [TBL] [Abstract][Full Text] [Related]  

  • 67. RAC-LATS1/2 signaling regulates YAP activity by switching between the YAP-binding partners TEAD4 and RUNX3.
    Jang JW; Kim MK; Lee YS; Lee JW; Kim DM; Song SH; Lee JY; Choi BY; Min B; Chi XZ; Bae SC
    Oncogene; 2017 Feb; 36(7):999-1011. PubMed ID: 27425596
    [TBL] [Abstract][Full Text] [Related]  

  • 68. YAP Expression and Activity Are Suppressed by S100A7 via p65/NFκB-mediated Repression of ΔNp63.
    Li Y; Kong F; Shao Q; Wang R; Hu E; Liu J; Jin C; He D; Xiao X
    Mol Cancer Res; 2017 Dec; 15(12):1752-1763. PubMed ID: 28923839
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Molecular chaperone Hsp27 regulates the Hippo tumor suppressor pathway in cancer.
    Vahid S; Thaper D; Gibson KF; Bishop JL; Zoubeidi A
    Sci Rep; 2016 Aug; 6():31842. PubMed ID: 27555231
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Epigenetic Silencing of LMX1A Contributes to Cancer Progression in Lung Cancer Cells.
    Wu TH; Chang SY; Shih YL; Chian CF; Chang H; Lin YW
    Int J Mol Sci; 2020 Jul; 21(15):. PubMed ID: 32751497
    [TBL] [Abstract][Full Text] [Related]  

  • 71. MicroRNA-135b promotes lung cancer metastasis by regulating multiple targets in the Hippo pathway and LZTS1.
    Lin CW; Chang YL; Chang YC; Lin JC; Chen CC; Pan SH; Wu CT; Chen HY; Yang SC; Hong TM; Yang PC
    Nat Commun; 2013; 4():1877. PubMed ID: 23695671
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Interferon Consensus Sequence-Binding Protein 8, a Tumor Suppressor, Suppresses Tumor Growth and Invasion of Non-Small Cell Lung Cancer by Interacting with the Wnt/β-Catenin Pathway.
    Ye L; Xiang T; Zhu J; Li D; Shao Q; Peng W; Tang J; Li L; Ren G
    Cell Physiol Biochem; 2018; 51(2):961-978. PubMed ID: 30466106
    [TBL] [Abstract][Full Text] [Related]  

  • 73. LIFR is a breast cancer metastasis suppressor upstream of the Hippo-YAP pathway and a prognostic marker.
    Chen D; Sun Y; Wei Y; Zhang P; Rezaeian AH; Teruya-Feldstein J; Gupta S; Liang H; Lin HK; Hung MC; Ma L
    Nat Med; 2012 Oct; 18(10):1511-7. PubMed ID: 23001183
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Circular RNA circ_0067741 regulates the Hippo/YAP pathway to suppress lung adenocarcinoma progression by targeting microRNA-183-5p.
    Mo J; Nie H; Zeng C; Han H; Xu P; Shi X
    Bioengineered; 2022 Apr; 13(4):10165-10176. PubMed ID: 35435136
    [TBL] [Abstract][Full Text] [Related]  

  • 75. PMEPA1 isoform a drives progression of glioblastoma by promoting protein degradation of the Hippo pathway kinase LATS1.
    Ji J; Ding K; Luo T; Xu R; Zhang X; Huang B; Chen A; Zhang D; Miletic H; Bjerkvig R; Thorsen F; Wang J; Li X
    Oncogene; 2020 Jan; 39(5):1125-1139. PubMed ID: 31605013
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Pasteurella multocida activates Rassf1-Hippo-Yap pathway to induce pulmonary epithelial apoptosis.
    Zhao G; Tang Y; Liu X; Li P; Zhang T; Li N; He F; Peng Y
    Vet Res; 2024 Mar; 55(1):31. PubMed ID: 38493147
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Hippo kinases regulate cell junctions to inhibit tumor metastasis in response to oxidative stress.
    Wang Y; Li J; Gao Y; Luo Y; Luo H; Wang L; Yi Y; Yuan Z; Jim Xiao ZX
    Redox Biol; 2019 Sep; 26():101233. PubMed ID: 31212215
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Knockdown of microRNA-103a-3p inhibits the malignancy of thyroid cancer cells through Hippo signaling pathway by upregulating LATS1.
    Zhang ML; Sun WH; Wu HQ; Liu ZD; Wang P
    Neoplasma; 2020 Nov; 67(6):1266-1278. PubMed ID: 32749848
    [TBL] [Abstract][Full Text] [Related]  

  • 79. LATS1 K751 acetylation blocks activation of Hippo signalling and switches LATS1 from a tumor suppressor to an oncoprotein.
    Yang S; Xu W; Liu C; Jin J; Li X; Jiang Y; Zhang L; Meng X; Zhan J; Zhang H
    Sci China Life Sci; 2022 Jan; 65(1):129-141. PubMed ID: 33945069
    [TBL] [Abstract][Full Text] [Related]  

  • 80. MCRS1 overexpression, which is specifically inhibited by miR-129*, promotes the epithelial-mesenchymal transition and metastasis in non-small cell lung cancer.
    Liu MX; Zhou KC; Cao Y
    Mol Cancer; 2014 Nov; 13():245. PubMed ID: 25373388
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.